Wheat Starch Granules are pharmaceutical excipient granules based on starch obtained from wheat and developed in a controlled granulated format for pharmaceutical formulation and processing applications. Wheat starch is a natural carbohydrate-based excipient with functional properties that can be useful in oral solid formulations.
According to the USP-NF monograph, Wheat Starch is obtained from the caryopsis of Triticum aestivum L. The International Pharmacopoeia describes wheat starch as having two characteristic types of granules: larger lenticular granules approximately 20–50 µm in diameter and smaller spherical granules approximately 5–10 µm in diameter.
The granulated form of wheat starch provides a controlled physical format for handling, blending, filling, and formulation development. The final characteristics of Wheat Starch Granules depend on the source material, processing conditions, granulation method, particle-size distribution, moisture, density, and other product-specific properties.
Wheat Starch Granules are granulated pharmaceutical excipient materials produced using wheat-derived starch as the primary component. Wheat starch is a naturally occurring polysaccharide consisting primarily of amylose and amylopectin.
The native starch structure gives wheat starch its characteristic granule morphology. The International Pharmacopoeia identifies the characteristic wheat starch granules as either lenticular or small spherical structures.
When processed into a finished granule format, wheat starch can provide a more controlled physical form for pharmaceutical manufacturing. Granulation may influence particle-size distribution, flowability, density, packing behavior, dust generation, and handling characteristics.
The exact physical characteristics of the finished Wheat Starch Granules should be established from the approved product specification.
Wheat starch is recognized as a pharmaceutical excipient. WHO's International Pharmacopoeia provides specifications and analytical procedures for pharmaceutical substances and excipients, and its starch material includes wheat starch.
Depending on the formulation and grade, starch-based excipients can contribute to several formulation functions. Wheat starch may be evaluated for applications involving binding, dilution, disintegration, or other physical roles in oral solid formulations.
The specific functionality of Wheat Starch Granules depends on the grade, processing history, particle characteristics, formulation composition, and manufacturing process.
One of the distinguishing characteristics of wheat starch is its granule morphology.
The International Pharmacopoeia describes two main wheat starch granule populations:
The hilum and striations are described as poorly visible.
This natural bimodal particle structure can be relevant when evaluating wheat starch during pharmaceutical formulation development.
For finished Wheat Starch Granules, the granulation process can create larger agglomerated particles while retaining the functional characteristics of the underlying starch material.
Particle-size distribution is an important quality attribute for granulated pharmaceutical excipients.
For Wheat Starch Granules, product-specific characteristics may include:
Particle size can influence flow, packing, segregation, blending, filling, hydration, and downstream formulation performance.
The actual particle-size limits should be established according to the finished-product specification rather than assigning a universal granule-size range.
Native starch powders can have different handling characteristics depending on particle morphology and moisture. A granulated form can provide a more controlled physical structure for material handling.
Flowability is influenced by:
Consistent flow can support blending, hopper transfer, filling, and other pharmaceutical processing steps.
Flowability should be established through appropriate product-specific testing.
Bulk density and tapped density are useful physical characteristics for evaluating Wheat Starch Granules.
Bulk density represents the mass per unit volume before standardized tapping, while tapped density provides information about the packing behavior after tapping.
These properties can influence:
Where actual measurements are available, Carr Index and Hausner Ratio can also be calculated to further characterize flow behavior.
Moisture is an important quality consideration for starch-based excipients. The International Pharmacopoeia monograph excerpt specifies a loss-on-drying limit for wheat starch of not more than 150 mg/g, equivalent to 15.0%, under the stated test conditions. It also specifies sulfated ash of not more than 6 mg/g (0.6%).
However, these values come from the referenced International Pharmacopoeia material and should not automatically be treated as the finished Wheat Starch Granules specification. The actual CMS specification should follow the standard and version applicable to the material being supplied.
Moisture can influence flowability, granule strength, packing, storage stability, and formulation performance.
Wheat starch is not freely soluble in cold water. Starch granules can absorb water and undergo changes in structure when heated in an aqueous environment.
Hydration behavior can be relevant to formulation development, particularly where starch is intended to contribute to swelling, binding, disintegration, or other functional properties.
The behavior of finished Wheat Starch Granules depends on particle size, granule structure, processing conditions, moisture, and the presence of other formulation components.
Specific dissolution or hydration claims should therefore be supported by product-specific testing.
Wheat Starch Granules can be evaluated for pharmaceutical formulation applications where a wheat-derived starch excipient in a controlled granulated format is required.
Potential applications include:
The actual function depends on the grade, formulation composition, processing method, and validated performance.
The manufacturing process used to produce Wheat Starch Granules can influence their physical characteristics.
Important process stages may include:
Process conditions should be controlled to obtain consistent particle characteristics and reproducible batch performance.
The final product should be tested against its approved specification before being released for pharmaceutical formulation use.
Quality control of Wheat Starch Granules should include identification of the wheat starch material together with appropriate physical and chemical quality attributes.
The International Pharmacopoeia describes analytical controls for starches including granule morphology, foreign matter, oxidizing matter, acidity, sulfated ash, iron, and loss on drying. For wheat starch specifically, the referenced monograph gives limits for iron, sulfated ash, loss on drying, acidity, foreign matter, and oxidizing matter.
Finished-product quality evaluation may include:
The exact acceptance criteria should be taken from the applicable pharmacopoeial standard and the approved finished-product specification.
Wheat Starch Granules can be incorporated into oral solid formulation development where the functional properties of starch are appropriate for the intended formulation.
Formulators may evaluate the material in combination with active ingredients and other excipients to determine its effect on:
The final formulation performance depends on the complete formulation rather than on wheat starch alone.
The functional characteristics of Wheat Starch Granules can vary with botanical source, processing conditions, particle size, moisture, and granulation process.
Important development attributes can include:
These properties should be evaluated according to the intended formulation and manufacturing process.
Because starch-based materials can interact with environmental moisture, suitable packaging and storage conditions should be established for Wheat Starch Granules.
Important considerations include:
The storage requirements should follow the validated stability program and product specification.
Wheat Starch Granules can be developed for:
The specific application should be selected according to the grade and validated functional performance.
Wheat Starch Granules are pharmaceutical excipient granules based on wheat-derived starch and developed in a controlled physical format for pharmaceutical formulation and manufacturing applications.
USP-NF defines Wheat Starch as starch obtained from the caryopsis of Triticum aestivum L. The International Pharmacopoeia identifies characteristic wheat starch granules as larger lenticular granules of approximately 20–50 µm and smaller spherical granules of approximately 5–10 µm.
The finished granule characteristics depend on the raw material, granulation process, particle-size distribution, moisture, density, flowability, and other product-specific parameters.
Wheat Starch Granules can therefore provide a controlled pharmaceutical excipient format for manufacturers and formulation developers requiring wheat-derived starch for oral solid formulation applications.
| Parameter | Specification |
|---|---|
| Appearance | White to off-white granules |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 1.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| pH (1% Solution) | 2.0 – 4.0 |
| Individual Impurity | NMT 0.5% |